Milmed is a patented method and a health-promoting agent based on 15 years of research into specially treated yeast cultures. The current patented therapeutic areas, all with the same technology and product, include inflammatory conditions, allergies, and neurodegenerative disorders.

The company’s product is now marketed as a food supplement, alnozine.com (with focus on allergies), but it is also on the journey of being registered as a medicinal product for the treatment of IBS.